September 11, 2015 Conference


Back to the Future: The NEW and OLD in Glaucoma

CME Objective Requirement 

Professional Practice Gaps: 

Using feedback from NEOS members and discussion by the Program Committee, Glaucoma diagnosis and treatment, new and old techniques were identified as a significant professional practice gap in our membership. 

Program Objectives: 

The content and format of this educational activity has been specifically designed to fill the identified practice gaps in our membership's current and potential scope of professional activities in a way that focuses on education, while managing commercial support and maintaining independence from promotional activities and commercial proprietary interests.


This program seeks to: 

1) Increase the competence of the audience in the areas of glaucoma diagnosis and management 

2) Improve the performance of the audience in clinical practice 

3) Improve outcomes in the area of patient care, surgery and risk management in caring for glaucoma patients

 


Visual field Interpretation: How is the test? Is it worse?
Angela Turalba

Morning program


Gonioscopy: Still “State of the Art” 100 Years After Salzmann’s First Look
M. Wallace Alward

Morning program


Molecular Genetics of Glaucoma: So What?
M. Wallace Alward

Morning program


Glaucoma Medical Treatment- tailoring treatment to the patient's needs
Paul Cotran

Morning program


Assessing Progression in Glaucoma
Michael Koval

Morning program


Glaucoma Surgery: Which Procedure, When, and Why
Babak Eliassi-Rad

Morning program


Glaucoma Risk Assessment
Susan Liang

Morning program


Glaucoma Technology Update: OCT and the Pipeline for Glaucoma Devices
Teresa C. Chen

Morning program


Pharmacology

Professional Practice Gaps:

-Limited knowledge of and experience with newer drug delivery technologies that are actively being investigated

-Lack of understanding of differences in currently used glaucoma drug pharmacology

-Lack of awareness of/experience with current agents used for surgical peri-operative treatment regimens

-Lack of awareness of/experience with different mechanism of actions of current and future dry eye therapies.

 

Program Objectives: 

1. Improve attendees’ ability to select appropriate agents for glaucoma therapy. 

2. Improve attendees’ understanding of the potential options of agents to be used for peri-operative therapy. 

3. Expand attendees’ knowledge of the options for treatment of ocular surface disease. 

4. Expand attendees’ knowledge of upcoming newer drug delivery technologies 

5. Improve attendees’ awareness of differences in formulations of medications used in clinical ophthalmology

 


Anti-Inflammatory Pharmacology
Shiyoung Roh

Afternoon program


Pharmacology of Glues and Sealants
Michael B. Raizman

Afternoon program


Targeting conventional outflow: Disease modifying glaucoma therapeutics
Dan Stamer

Afternoon program


Drug Delivery – Glaucoma Treatment in Development
Steve Simmons

Afternoon program


Formulation and Preservatives in Eye Drops
Michael Pokabla

Afternoon program


Pharmacology of Ocular Surface Disease Therapy
Helen K. Wu

Afternoon program


Pharmacology of anti-infective therapy
Jessica Chow

Afternoon program


Pharmacology of current glaucoma therapy
Kimberly Miller

Afternoon program